Akash Sethi, Promoter & Joint MD, acquired 1,65,355 equity shares of Shree Pacetronix via off-market transfer on March 20, 2026.
Shares were transferred from Bio Pace Technology INC, raising Sethi's voting stake from 4.35% to 8.76% of existing equity capital.
Post-acquisition, Sethi's total diluted holding (including warrants) stands at 12.28% of the fully diluted share capital.